SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy

Autor:	Dominique Croteau, Tomas Baka, Sara Young, Huamei He, Jordan M. Chambers, Fuzhong Qin, Marcello Panagia, David R. Pimentel, James A. Balschi, Wilson S. Colucci, Ivan Luptak
Rok vydání:	2023
Předmět:	Pharmacology General Medicine
Zdroj:	Biomedicine & Pharmacotherapy. 160:114310
ISSN:	0753-3322
DOI:	10.1016/j.biopha.2023.114310
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::25f9f4056a86a27dbd881facac28badd https://doi.org/10.1016/j.biopha.2023.114310 Zobrazit plný text záznamu Full Text from ScienceDirect